STAAR Surgical Designates Deborah Andrews as New Chief Financial Officer
Well, buckle up, folks! STAAR Surgical Company, that NASDAQ-listed powerhouse (ticker symbol: STAA), has some exciting news to share. Get ready to meet Deborah Andrews, the fresh face taking over as the company's Chief Financial Officer, effective June 25, 2025. 🌟
But wait a minute, who's Deborah Andrews, you ask? Well, she's no stranger to the STAAR tribe. Before claiming her CFO crown in June, Deborah spent a substantial chunk of her career within our beloved organization. She initially joined STAAR way back in 1995, serving in various accounting and finance leadership roles. In fact, she has graced the CFO seat twice: first from 2005 to 2013, and then again from September 2017 until her retirement in June 2020. Talk about a lifelong commitment to STAAR! 💙
When retirement knocked, Deborah wasn't done contributing. She returned to STAAR in March 2025 as Interim CFO, and now, she's back on the scene permanently. This woman's dedication is unparalleled! 💪
If you're curious about Deborah's resume outside of STAAR, she's been sitting pretty on the Board of Directors of Lineage Cell Therapeutics since April 2014. Naturally, she serves as Audit Committee Chair, and she's also led the Compensation Committee. Impressive, right? And before Lineage Cell Therapeutics, remember that accountant gig at KPMG from 1991 to 1994? It played a crucial role in Deborah's amazing career journey. 📈
And for the trivia buffs, Deborah holds a Bachelor of Science degree in accounting from California State University at San Bernardino. Fascinating, isn't it? 🎓
So there you have it, folks! Deborah Andrews is stepping into her new role as STAAR Surgical's CFO. With her extensive experience, we're confident she's the perfect fit to drive us forward on our ambitious journey. Let's give a warm STAAR welcome to Deborah Andrews! 🎉🎉🎉
Deborah Andrews' extensive experience in finance and business spans across multiple careers, as she had served on the Board of Directors of Lineage Cell Therapeutics and held various accounting and finance leadership roles at STAAR Surgical, including her recent return as Interim CFO, with her first stint as CFO from 2005 to 2013 and her second from September 2017 to June 2020.
In addition to her impressive career in business and finance, Deborah Andrews has played a significant role in shaping the future of STAAR Surgical Company, as she will now be assuming the position of CFO permanently, starting in June 2025.
